General Information of the Compound
Compound ID
CP0186922
Compound Name
(15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.02,7.012,18]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one
    Show/Hide
Synonyms
PF 3644022
PF-3644022
PF3644022
    Show/Hide
Structure
Formula
C21H18N4OS
Molecular Weight
374.469
Canonical SMILES
C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccc(C)nc2)C(=O)N1
    Show/Hide
InChI
InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1
    Show/Hide
InChIKey
CMWRPDHVGMHLSZ-GFCCVEGCSA-N
Physicochemical Property
logP
4.36372
Rotatable Bonds
1
Heavy Atom Count
27
Polar Areas
66.91
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44631903
SID: 87793385
ChEMBL ID
CHEMBL1231206
DrugBank ID
DB07430
Clinical Information about the Compound
Drug 1 ( PF-3644022 )
Drug Name PF-3644022
Target(s)
MAPK-activated protein kinase 2 (MAPKAPK2)
Inhibitor